Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Brain Injuries D001930 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Cluster Headache D003027 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Viremia D014766 4 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Qu XW et al. Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. 1998 J. Physiol. (Lond.) pmid:9729632
Ibe BO et al. Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb. 1998 J. Appl. Physiol. pmid:9729586
Matsumoto K et al. Eosinophilic airway inflammation induced by repeated exposure to cigarette smoke. 1998 Eur. Respir. J. pmid:9727790
Rougier F and Denizot Y Platelet-activating factor and the growth of fibroblasts. 1998 Mol. Carcinog. pmid:9726813
Beyer AJ et al. PAF and CD18 mediate neutrophil infiltration in upper gastrointestinal tract during intra-abdominal sepsis. 1998 Am. J. Physiol. pmid:9724257
Mazer BD et al. Dose-dependent agonist and antagonist effects of the platelet-activating factor analogue 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine on B lymphocytes. 1998 J. Allergy Clin. Immunol. pmid:9723666
Karzai W et al. [Current aspects of immunomodulatory therapy initiation for sepsis]. 1998 Dtsch. Med. Wochenschr. pmid:9721572
Tsai IL et al. Anti-platelet aggregation constituents from Formosan Toddalia asiatica. 1998 Phytochemistry pmid:9720317
Tamaoki J et al. A human bronchial epithelial cell line releases arginine vasopressin: involvement of Ca2+ -activated K+ channels. 1998 Regul. Pept. pmid:9712168
Hilliquin P et al. A double blind, placebo controlled study of a platelet activating factor antagonist in patients with rheumatoid arthritis. 1998 J. Rheumatol. pmid:9712091
Pei Y et al. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. 1998 J. Immunol. pmid:9712066
Pérez-Arellano JL et al. BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis. 1998 Mediators Inflamm. pmid:9705608
Boulay F et al. Phagocyte chemoattractant receptors. 1997 Ann. N. Y. Acad. Sci. pmid:9704038
Thakur A and Willcox MD Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases. 1998 Exp. Eye Res. pmid:9702174
Akisü M et al. Platelet-activating factor levels in term and preterm human milk. 1998 Biol. Neonate pmid:9701651
Pennings HJ et al. Tumour necrosis factor-alpha induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro. 1998 Eur. Respir. J. pmid:9701413
Andersson R et al. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats. 1998 Pancreas pmid:9700940
Koyama S et al. Human lung fibroblasts release chemokinetic activity for monocytes constitutively. 1998 Am. J. Physiol. pmid:9700081
Alves AC et al. Effect of selective phosphodiesterase inhibitors on the rat eosinophil chemotactic response in vitro. 1997 Mem. Inst. Oswaldo Cruz pmid:9698934
DeCoster MA et al. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons. 1998 J. Neurosci. Res. pmid:9698157